Product Description
| Brand |
Abbott |
| Sample Type |
Whole Blood/ Plasma |
| Pack Size |
25T |
| CAT No |
03P92-25 |
The i-STAT CK-MB test is an in vitro diagnostic test for the quantitative measurement of creatine kinase MB mass in whole blood or plasma samples. CK-MB measurements can be used as an aid in the diagnosis and treatment of myocardial infarction (MI).
Rapid and Reliable Cardiac Biomarker TestingFeaturing advanced electrochemical biosensor technology, the Abbott i-STAT CK-MB Cartridge enables fast and accurate detection of Creatine Kinase-MB. Each cartridge is designed to support prompt clinical decisions, providing results within approximately 10 minutes using minimal blood or plasma sample volumes.
Simplified Workflow for Healthcare ProfessionalsSingle-use, individually sealed cartridges offer straightforward operation-simply insert the cartridge into the compatible i-STAT Handheld Analyzer. Built-in electronic and procedural controls ensure result integrity, and no external power source is required, making these cartridges easy to implement in a variety of clinical and emergency settings.
Safe, Compliant, and TraceableThe cartridges meet stringent international regulatory standards (CE marked, FDA approved) and each includes lot and expiry tracking. After each use, disposability and biohazard designations support safe handling and prevent cross-contamination. Proper storage at 2-8C maximizes shelf life and performance reliability.
FAQ's of Abbott i-STAT CK-MB CARTRIDGE:
Q: How is the Abbott i-STAT CK-MB Cartridge used at the point of care?
A: The cartridge is manually inserted into the Abbott i-STAT Handheld Analyzer after collecting approximately 17-20 L of whole blood or plasma (treated with heparin or EDTA). Once inserted, automated analysis delivers quantitative CK-MB results within about 10 minutes.
Q: What are the benefits of using the CK-MB Cartridge in emergency settings?
A: With rapid, real-time operation and minimal sample volume required, the CK-MB Cartridge allows clinicians to promptly assess cardiac biomarker levels, supporting timely intervention for suspected cardiac events directly at the patient's bedside.
Q: When should the cartridges be disposed of, and what is the recommended procedure?
A: Each cartridge is intended for single use. After testing, dispose of the cartridge immediately as biohazardous waste according to institutional safety protocols to ensure proper infection control.
Q: Where should I store Abbott i-STAT CK-MB Cartridges to maintain optimal shelf life?
A: Store cartridges refrigerated at 2-8C. Do not freeze. Always check the expiration date printed on each cartridge label before use to ensure analytical accuracy.
Q: What quality control measures are in place for this cartridge?
A: Each cartridge incorporates onboard electronic and procedural controls, ensuring valid performance and reliable results with every analysis. Lot and expiration details are included on each label for traceability.
Q: Who is the intended user of the i-STAT CK-MB Cartridge, and in what settings is it suitable?
A: Abbott i-STAT CK-MB Cartridges are designed for use by healthcare professionals, including in clinical laboratories, emergency departments, hospitals, and other point-of-care environments needing fast cardiac biomarker testing.
Q: What equipment do I need to perform the CK-MB test with this cartridge?
A: You need the Abbott i-STAT Handheld Analyzer, as the cartridge is compatible exclusively with this device, which provides automated and real-time analysis for CK-MB quantification.